DLX6-AS1 Regulates Odonto/osteogenic Differentiation in Dental Pulp Cells Under the Control of BMP9 Via the MiR-128-3p/MAPK14 Axis: A Laboratory Investigation
Overview
Authors
Affiliations
Aim: The regenerative capacity of dental pulp relies on the odonto/osteogenic differentiation of dental pulp cells (DPCs), but dynamic microenvironmental changes hinder the process. Bone morphogenetic protein 9 (BMP9) promotes differentiation of DPCs towards an odonto/osteogenic lineage, forming dentinal-like tissue. However, the molecular mechanism underlying its action remains unclear. This study investigates the role of DLX6 antisense RNA 1 (DLX6-AS1) in odonto/osteogenic differentiation induced by BMP9.
Methodology: Custom RT profiler PCR array, quantitative Real-Time PCR (qRT-PCR) and western blots were used to investigate the expression pattern of DLX6-AS1 and its potential signal axis. Osteogenic ability was evaluated using alkaline phosphatase and alizarin red S staining. Interactions between lncRNA and miRNA, as well as miRNA and mRNA, were predicted through bioinformatic assays, which were subsequently validated via RNA immunoprecipitation and dual luciferase reporter assays. Student's t-test or one-way ANOVA with post hoc Tukey HSD tests were employed for data analysis, with a p-value of less than .05 considered statistically significant.
Results: DLX6-AS1 was upregulated upon BMP9 overexpression in DPCs, thereby promoting odonto/osteogenic differentiation. Additionally, miR-128-3p participated in BMP9-induced odonto/osteogenic differentiation by interacting with the downstream signal MAPK14. Modifying the expression of miR-128-3p and transfecting pcMAPK14/siMAPK14 had a rescue impact on odonto/osteogenic differentiation downstream of DLX6-AS1. Lastly, miR-128-3p directly interacted with both MAPK14 and DLX6-AS1.
Conclusions: DLX6-AS1 could regulate the odonto/osteogenic differentiation of DPCs under the control of BMP9 through the miR-128-3p/MAPK14 axis.
BMP9 enhances osteogenic differentiation in rheumatoid arthritis: a potential therapeutic approach.
Zhang H, Dang Z, Wang X, Wang C, Zhang H, Zhang Y J Transl Med. 2025; 23(1):241.
PMID: 40022220 PMC: 11869551. DOI: 10.1186/s12967-025-06309-5.
Chen Y, Sha W, Zhang Y, Kou W, Yang L, Guo R Open Med (Wars). 2024; 19(1):20241073.
PMID: 39588384 PMC: 11587921. DOI: 10.1515/med-2024-1073.